COX15
protein-codingcytochrome c oxidase assembly homolog COX15, the group of Mitochondrial respiratory chain complex assembly factors
Gene summary
Cytochrome c oxidase (COX), the terminal component of the mitochondrial respiratory chain, catalyzes the electron transfer from reduced cytochrome c to oxygen. This component is a heteromeric complex consisting of 3 catalytic subunits encoded by mitochondrial genes and multiple structural subunits encoded by nuclear genes. The mitochondrially-encoded subunits function in electron transfer, and the nuclear-encoded subunits may function in the regulation and assembly of the complex. This nuclear gene encodes a protein which is not a structural subunit, but may be essential for the biogenesis of COX formation and may function in the hydroxylation of heme O, according to the yeast mutant studies. This protein is predicted to contain 5 transmembrane domains localized in the mitochondrial inner membrane. Alternative splicing of this gene generates two transcript variants diverging in the 3' region. [provided by RefSeq, Jul 2008]
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~21.3 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0044970
Submitter: ClinGen
The relationship between *COX15* and primary mitochondrial disease was evaluated using the ClinGen Clinical Validity Framework as of December 4, 2023. *COX15* encodes the cytochrome c oxidase assembly protein COX15 homolog protein, a transmembrane protein located at the mitochondrial inner membrane. *COX15* is a Complex IV assembly factor with is thought to be involved in the biosynthesis of heme A. Defects of this protein lead to complex IV deficiency. *COX15* was first reported in relation to autosomal recessive primary mitochondrial disease in 2003 in an individual with fatal, infantile hypertrophic cardiomyopathy (PMID: 12474143). While various names could be given to the constellation of features seen in those with *COX15*-related disease, pathogenic variants in this gene cause a primary mitochondrial disease. Therefore, the *COX15* phenotype has been lumped into one disease entity according to the ClinGen Lumping and Splitting Framework. Of note, *COX15* was previously curated by this GCEP on April 22, 2019 (SOP Version 6) as having a Limited association with Leigh Syndrome Spectrum (LSS). The scope of this current curation encompassed cases of primary mitochondrial disease, which includes LSS. Evidence supporting the gene-disease relationship between *COX15* and primary mitochondrial disease includes case-level data and experimental data. This curation includes six unique variants (four missense including the p.Arg217Trp variant that appears to be recurrent as it was scored in five probands from different populations, one nonsense, one splicing) in nine probands from nine publications (PMIDs: 15235026, 12474143, 15863660, 21412973, 26959537, 32232962, 33746038, 34440436, 31967322). Affected individuals present with a broad phenotypic spectrum of disease which may include seizures, hypotonia, ataxia, psychomotor retardation, vision loss, dysphagia, microcephaly, encephalopathy, and gliosis as well as cardiomyopathy. MRI findings are often consistent with LSS. The age of onset ranges from birth to early childhood. Where assessed, affected individuals present with persistent lactic acidosis and complex IV deficiency. Loss of function is implicated as the mechanism of disease. This gene-disease association is also supported by known biochemical function, functional alteration in patient fibroblasts, and a mouse model which recapitulates aspects of mitochondrial disease (PMIDs: 33340416, 12474143, 21723506, 26039449). In summary, there is definitive evidence to support this gene-disease relationship, including that more than three years have elapsed from the first proposal of the association. This classification was approved by the NICHD/NINDS U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on December 4, 2023 (SOP Version 9).
Inheritance Pattern: AR
Disease ID:MONDO:0009723
Submitter: ClinGen
The relationship between COX15 and Leigh syndrome spectrum was evaluated using the ClinGen Clinical Validity Framework as of April 22, 2019. 11 articles were reviewed. COX15 was first reported in relation to autosomal recessive Leigh syndrome spectrum in 2004 (Oquendo et al., PMID: 15235026). Five unique variants predicted to cause a loss of or reduced function of the protein have been reported in ClinVar. Complex IV deficiency is the mechanism of disease for this gene. Evidence supporting this gene-disease relationship includes case-level data and experimental data. Variants in this gene have been reported in at least 1 proband with Leigh syndrome spectrum in 1 publication (PMID 15235026 ). This gene-disease association is further supported by the function of the gene product, expression, and studies in patient cell lines and a COX15 mouse model. In summary, there is limited evidence to support the relationship between COX15 and autosomal recessive Leigh syndrome spectrum. This classification was approved by the NICHD U24 ClinGen Mitochondrial Disease Gene Curation Expert Panel on April 22, 2019 (SOP Version 6).
Inheritance Pattern: AR
Disease ID:MONDO:0014051
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0014051
Submitter: G2P
Inheritance Pattern: AR
Disease ID:MONDO:0014051
Submitter: Labcorp Genetics (formerly Invitae)
Clinical Genomic Database (CGD)
Manifestation: Biochemical; Cardiovascular; Musculoskeletal; Neurologic
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to COX15 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_078470.6. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 4 | 112 | 1 | 117 | ||
| missense | 1 | 5 | 109 | 13 | 128 | |
| nonsense | 6 | 9 | 2 | 17 | ||
| start loss | 0 | |||||
| frameshift | 11 | 4 | 2 | 17 | ||
| splice donor/acceptor (+/-2bp) | 14 | 1 | 15 | |||
| Total | 18 | 32 | 118 | 125 | 1 | 294 |
Highest pathogenic variant AF is 0.0003302203
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_510870.1 | 9 | MANE Select | |
| Ensembl | ENSP00000016171.6 | 9 | MANE Select | |
| RefSeq | NP_001307903.1 | 9 | Standard | |
| RefSeq | NP_001307904.1 | 7 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Thermogenesis - Homo sapiens (human)
- Oxidative phosphorylation - Homo sapiens (human)
- Porphyrin and chlorophyll metabolism - Homo sapiens (human)
- Hereditary Coproporphyria (HCP)
- Porphyria Variegata (PV)
Biological Process
- mitochondrial electron transport, cytochrome c to oxygen
- heme biosynthetic process
- heme a biosynthetic process
- respiratory gaseous exchange
- respiratory chain complex IV assembly
Molecular Function
- cytochrome-c oxidase activity
- protein binding
- oxidoreductase activity, acting on the CH-CH group of donors
- oxidoreductase activity, acting on NAD(P)H, heme protein as acceptor
Cellular Component
- nucleus
- mitochondrion
- mitochondrial inner membrane
- mitochondrial respirasome
- integral component of membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000016171
- Coding exons
- 9
- Length
- 20257
- Individuals with no LoFs
- 125617
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 131
- Defined
- 125748
- p
- 0.000521
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.262 | 208 | 219 | 0.950 | 0.0000123 | 2603 |
| Missense (PolyPhen) | 72 | 80.559 | 0.89375 | 967 | ||
| Synonymous | -0.177 | 87 | 84.9 | 1.02 | 0.00000448 | 870 |
| Loss of Function | 0.348 | 21 | 22.8 | 0.921 | 0.00000128 | 253 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.00031 | 0.00031 | rare |
| Latino/Admixed American | 0.00064 | 0.00064 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.00033 | 0.00033 | rare |
| Finnish | 0.000046 | 0.000046 | rare |
| European (Non-Finnish) | 0.00069 | 0.00069 | rare |
| South Asian | 0.00039 | 0.00039 | rare |
| Other | 0.0011 | 0.0011 | notable |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May be involved in the biosynthesis of heme A. {ECO:0000269|PubMed:12474143}.;
- Disease
- DISEASE: Leigh syndrome (LS) [MIM:256000]: An early-onset progressive neurodegenerative disorder characterized by the presence of focal, bilateral lesions in one or more areas of the central nervous system including the brainstem, thalamus, basal ganglia, cerebellum and spinal cord. Clinical features depend on which areas of the central nervous system are involved and include subacute onset of psychomotor retardation, hypotonia, ataxia, weakness, vision loss, eye movement abnormalities, seizures, and dysphagia. {ECO:0000269|PubMed:15235026, ECO:0000269|PubMed:15863660}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.147
Intolerance Scores
- LoFtool
- 0.167
- RVIS EVS
- -0.25
- RVIS percentile EVS
- 36.07
Essentials
- Essential (CRISPR)
- E
- Essential (CRISPR2)
- E
- Essential (gene trap)
- E
- Indispensability pred.
- E
- Indispensability score
- 0.990
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |